机译:胸腺酮抑制磷酸酯诱导的NF-Kappa B和COX-2的表达,并诱导体内小鼠皮肤中的细胞保护酶的表达
College of Pharmacy Keimyung University Daegu 704-701 South Korea;
Keimyung Univ Coll Pharm Taegu 704701 South Korea;
Tumor Microenvironment Global Core Research Center College of Pharmacy Seoul National University;
Seoul Natl Univ Coll Pharm Tumor Microenvironm Global Core Res Ctr Seoul 151742 South Korea;
Tumor Microenvironment Global Core Research Center College of Pharmacy Seoul National University;
Seoul Natl Univ Coll Pharm Tumor Microenvironm Global Core Res Ctr Seoul 151742 South Korea;
Tumor Microenvironment Global Core Research Center College of Pharmacy Seoul National University;
Seoul Natl Univ Coll Pharm Tumor Microenvironm Global Core Res Ctr Seoul 151742 South Korea;
Thymoquinone; Cyclooxygenase-2; Nuclear factor-kappaB; Cytoprotective enzymes; Mouse skin;
机译:胸腺酮抑制磷酸酯诱导的NF-Kappa B和COX-2的表达,并诱导体内小鼠皮肤中的细胞保护酶的表达
机译:胸腺醌在体内抑制佛波酯诱导的NF-κB活化和COX-2的表达,并诱导细胞保护酶在小鼠皮肤中的表达
机译:胸腺醌在体内抑制佛波酯诱导的NF-κB活化和COX-2的表达,并诱导细胞保护酶在小鼠皮肤中的表达
机译:白藜芦醇抑制菲尔伯酯诱导的小鼠皮肤中的环氧酶-2表达:MAPK和AP-1作为潜在的分子靶标
机译:选择性COX-2抑制剂塞来昔布对鼻咽癌细胞系中增殖,凋亡和差异蛋白表达的影响。
机译:Celecoxib抑制Phorbol酯诱导的小鼠皮肤肿瘤促进和COX-2表达:C / EBP作为潜在的分子靶标
机译:随着NF-κB和AP-1的激活,HUMURORE通过阻断NF-κB和AP-1:IκB激酶和C-JUN-N-末端激酶作为各自的上游靶标,抑制了小鼠皮肤中的Phorbol酯诱导的COX-2表达